Printer Friendly

Australia,United Kingdom : Norton Rose Fulbright advises Ferrier Hodgson on its planned merger with KPMG Australia.

Global law firm Norton Rose Fulbright has advised Ferrier Hodgson on its plan to merge with giant international professional services firm KPMG.

The deal, announced by the two firms on March 14, aims to create one of Australias largest restructuring services and forensic advisory businesses. It is scheduled for completion by 30 June 2019.

Ferrier Hodgson was created in 1976 and is one of Australias first independent firms specialising in restructuring, forensic, performance improvement and financial advisory. Under the terms of the deal, KPMG Australia will acquire Ferrier Hodgsons business located in Sydney, Melbourne, Brisbane and Perth, with expectations the Adelaide office will follow shortly.

A Norton Rose Fulbright team advised Ferrier Hodgson on all legal elements of the agreement, as well as assisting Ferrier Hodgson to manage its many stakeholders.

Norton Rose Fulbright partner Jeremy Wickens commented:

The strength of professional services firms is in their people, and the challenges of the transaction lay in ensuring that diverse expectations were addressed. We are pleased that we were able to assist Ferrier Hodgson in a way that addressed these challenges and resulted in a very satisfactory outcome for the firm and its partners.

The team was led by corporate partner Jeremy Wickens and financial restructuring and insolvency partner Steve Palmer, and was supported by corporate associates Christopher Langton, Julia Sonza and Ellen Laughton.

[c] 2019 Al Bawaba ( Provided by SyndiGate Media Inc. ( ).

COPYRIGHT 2019 SyndiGate Media Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2019 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Mena Report
Geographic Code:8AUST
Date:Mar 18, 2019
Previous Article:Switzerland : FDA grants Roches Tecentriq in combination with Abraxane accelerated approval for people with PD-L1-positive, metastatic...
Next Article:United Kingdom : Norton Rose Fulbright-authored report on renewable PPAs launches.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters